97141 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
Spider silk fusion protein structures without repetitive fragment for binding to an organic target
#302METHODS FOR PREVENTING BIOFILM FORMATION
#303BINDING MOIETIES FOR BIOFILM REMEDIATION
#304Cross-reactive antibody
#305Chromatography matrices including novel protein a based ligands
#306Compositions and methods including recombinant B lymphocyte cell line including an exogenously incorporated nucleic acid expressing an exogenous membrane immunoglobulin reactive to a first antigen and including an endogenous gene expressing an endogenous secreted immunoglobulin reactive to a second antigen
#307Compositions and methods related to protein A (SpA) variants
#308Antibody binding microbial heparin binding motif to retard or prevent microbial biofilm formation on implanted medical devices
#309High affinity antibodies that neutralize enterotoxin B
#310Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#311PROTECTIVE VACCINE BASED ON STAPHYLOCOCCUS AUREUS SA2074 PROTEIN
#312Anti-glucosaminidase passive immunization for infections
#313Anti-wall teichoic antibodies and conjugates
#314ANTI-WALL TEICHOIC ANTIBODIES AND CONJUGATES
#315Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response
#316Immunogenic composition comprising Panton-Valentine Leukocidin (PVL) derived polypeptides
#317Devices and methods for detection of Panton-Valentine Leukocidin (PVL)
#318STAPHLOCOCCUS AUREUS ALPHA-HEMOLYSIN ANTIBODIES
#319Human monoclonal antibodies and methods for producing the same
#320Gram-positive bacteria specific binding compounds
#321Peptide or arrangement of peptides forming a epitope binding site
#322THERAPEUTIC AGENT FOR USE IN A METHOD OF TREATING PSORIASIS OR ATOPIC DERMATITIS
#323ANTIBODY AND ANTIBODY-CONTAINING COMPOSITION
#324ADJUVANT THERAPY FOR STAPHYLOCOCCAL INFECTION WITH ENTEROTOXIN SPECIFIC MABS
#325METHOD FOR INCREASING DEPOSITION OF COMPLEMENT C3b ON BACTERIAL SURFACE AND PHAGOCYTOSIS BY PHAGOCYTE AND A THERAPEUTIC METHOD AND A THERAPEUTIC AGENT FOR BACTERIAL INFECTIONS
#326AFFINITY MEDIUM USING FIXED WHOLE CELLS
#327Compositions and methods related to antibodies to staphylococcal protein A
#328Methods for producing recombinant proteins
#329Anti-infective binding proteins that bind AIP2
#330Protein for affinity-separation matrix
#331Human binding molecules having killing activity against enterococci
#332polypeptide and antibodies
#333Process for producing protein A-like protein with use of genus bacterium
#334Immunogenic composition comprising alpha-hemolysin oligopeptides
#335Antibodies that specifically bind alpha toxin and methods of use
#336Antibodies or fragments thereof directed against a epitope of IsaA or IsaB
#337High affinity antibodies that neutralize enterotoxin B
#338Immunoglobulin-binding proteins with improved specificity
#339Targeting poly-gamma-glutamic acid to treat and related infections
#340DEPLETED ANTI-STAPHYLOCOCCAL ENTEROTOXINS POLYCLONAL ANTIBODIES, PREPARATION AND USES THEREOF
#341COMPOSITIONS AND METHODS RELATED TO ANTIBODIES TO STAPHYLOCOCCAL PROTEINS ISDA OR ISDB
#342Staphylococcus aureus Specific Human Recombinant Polyclonal Antibodies and Uses Thereof
#343Immunogenic compositions of antigens
#344Affinity chromatography matrix
#345Soluble heavy-chain only antibodies
#346Gram-positive bacteria specific binding compounds
#347Gram-positive bacteria specific binding compounds
#348Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#349Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
#350High affinity antibodies that neutralize enterotoxin B
#351Compositions and methods including recombinant B lymphocyte cell line including an exogenously incorporated nucleic acid expressing an exogenous membrane immunoglobulin reactive to a first antigen and including an endogenous gene expressing an endogenous secreted immunoglobulin reactive to a second antigen
#352specific antibodies and uses thereof
#353Compositions and methods including recombinant B lymphocyte cell line including at least one endogenous gene expressing at least one endogenous membrane immunoglobulin reactive to a first antigen and including at least one exogenously incorporated nucleic acid expressing at least one exogenous secreted immunoglobulin reactive to a second antigen
#354PROTECTIVE VACCINE BASED ON STAPHYLOCOCCUS AUREUS PROTEIN SA2412
#355Anti-glucosaminidase passive immunization for infections
#356leukocidins, therapeutic compositions, and uses thereof
#357Protein a crystals and cross-linked crystals and methods of use thereof
#358Chromatography matrices including novel protein A based ligands
#359Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
#360CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS CLUMPING FACTOR A IN COMPLEX WITH FIBRINOGEN DERIVED PEPTIDE AND USES THEREOF
#361Method for identification, isolation and production of antigens to a specific pathogen
#362Monoclonal antibodies against PBP2A derived from MRSA and methods of use
#363BACTEREMIA-ASSOCIATED ANTIGEN FROM STAPHYLOCOCCUS AUREUS
#364Methods of treating and preventing infections and associated conditions
#365THERAPEUTIC AGENT FOR USE IN A METHOD OF TREATING PSORIASIS OR ATOPIC DERMATITIS
#366Human binding molecules against and
#367Methods for producing recombinant proteins
#368Targeting poly-gama-glutamic acid to treat and related infections
#369Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
#370Poly-n-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#371Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#372Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#373Human monoclonal antibody against derived alpha-toxin and its use in treating or preventing abscess formation
#374Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#375Monoclonal antibodies against the PBP2-A protein and homologous sequences for the treatment of infections by and immunodiagnostics of bacteria of the phylum
#376Immunogenic composition comprising variants of clumping factor A
#377High affinity antibodies that neutralize enterotoxin B
#378polypeptides and antibodies
#379Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#380Gram-positive bacteria specific binding compounds
#381Soluble “heavy-chain only” antibodies
#382SPECIFIC ANTIBODY SELECTION BY SELECTIVE ELUTION CONDITIONS
#383Human binding molecules having killing activity against staphylococci and uses thereof
#384Immunogenic compositions of antigens
#385Antibodies or fragments thereof directed against a epitope of ISAA or ISAB
#386Detection method for methicillin resistant staphylococcus aureus
#387Recombinant alpha-hemolysin polypeptide of , having a deletion in the stem domain and heterologous sequences inserted
#388Human monoclonal antibodies and methods for producing the same
#389Capsular gram-positive bacteria bioconjugate vaccines
#390Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#391leukocidins, therapeutic compositions, and uses thereof
#392Nanoaggregate Embedded Beads Conjugated To Single Domain Antibodies
#393Human binding molecules having killing activity against enterococci and uses thereof
#394Compositions and Methods Related to Bacterial EAP, EMP, and/or ADSA Proteins
#395Reagents, methods, and systems for detecting methicillin-resistant
#396COMPOSITIONS AND METHODS FOR PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTION
#397Compositions and methods for the removal of biofilms
#398Toxin detection method
#399Targeting poly-γ-glutamic acid to treat and related infections
#400Compositions and methods related to bacterium proteins
#401Antigen-binding proteins that inhibit superantigens for the treatment of skin diseases
#402TREATMENT OF MICROBIAL INFECTIONS
#403Methods and compositions relating to synthetic β-1,6 glucosamine oligosaccharides
#404Antigen-Binding Proteins Targeting S. Aureus Orf0657n
#405polypeptides and antibodies
#406Staphylococcus aureus-specific antibody preparations
#407Methods and compositions related to immunizing against lung disease and conditions
#408Method for identification, isolation and production of antigens to a specific pathogen
#409GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS
#410Immunogenic composition
#411Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#412Anti-bacterial antibodies
#413PREVENTION OF STAPHYLOCOCCUS BIOFILM FORMATION
#414Antibody-mediated disruption of quorum sensing in bacteria
#415OPSONIC AND PROTECTIVE ANTIBODIES SPECIFIC FOR LIPOTEICHOIC ACID OF GRAM POSITIVE BACTERIA
#416OPSONIC MONOCLONAL AND CHIMERIC ANTIBODIES SPECIFIC FOR LIPOTEICHOIC ACID OF GRAM POSITIVE BACTERIA
#417Polynucleotides encoding humanized and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
#418Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#419Monoclonal antibodies recognizing a coagulase-negative protein
#420Immunoglobulins directed to bacterial, viral and endogenous polypeptides
#421VACCINE FOR STAPHYLOCOCCAL INFECTIONS
#422ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657n
#423Multicomponent vaccines
#424AFFINITY PURIFIED HUMAN POLYCLONAL ANTIBODIES AND METHODS OF MAKING AND USING THEM
#425Toxin detection method
#426Immunoglobulin-binding proteins with improved specificity
#427ANTIBODY WITH PROTEIN A SELECTIVITY
#428Crystal structure of clumping factor A in complex with fibrinogen derived peptide and uses thereof
#429Anti-antibodies
#430fibrinogen binding protein gene
#431Method for isolation of soluble polypeptides
#432SET1 proteins and uses thereof
#433Surface proteins from coagulase-negative staphylococci and that generate cross-reactive monoclonal and polyclonal antibodies
#434Human binding molecules having killing activity against enterococci and uses thereof
#435ANTIBODY WITH PROTEIN A SELECTIVITY
#436Inhibitors of S. aureus SdrD protein attachment to cells and uses therefor
#437Human binding molecules having killing activity against staphylococci and uses thereof
#438IMMUNOGENIC COMPOSITION
#439Use of panton-valentine leukocidin for treating and preventing staphylococcus infections
#440Use of alpha-toxin for treating and preventing staphylococcus infections
#441polypeptides
#442Method of passive immunization
#443PROTECTIVE STAPHYLOCOCCUS AUREUS VACCINE BASED ON CELL WALL-ASSOCIATED PROTEINS
#444Antibody diversity generation
#445Targeting Poly-Gamma-Glutamic Acid to Treat Staphylococcus Epidermidis and Related Infections
#446Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#447Compositions and methods for treating or preventing pneumococcal infection
#448TREATMENT OF MICRO-ORGANISM INFECTION
#449Methods and Compositions for the Treatment and Prevention of Staphylococcus Infections
#450Isolated Broadly Reactive Opsonic Immunoglobulin for Treating a Pathogenic Coagulase-Negative Staphylococcus Infection
#451Method for improving antibody
#452Methods and Compositions for the Treatment and Prevention of Staphylococcus Aureus Infections Through Interference With OPUC Operon Interaction with TRAP
#453Use of alpha-toxin for treating and preventing staphylococcus infections
#454Modified plant viruses and methods of use thereof
#455Antibody with protein A selectivity
#456Immunogenic composition
#457Immunogenic Composition for Use in Vaccination Against Staphylococcei
#458Immunogenic Composition
#459STAPHYLOCOCCUS AUREAS SPECIFIC ANTI-INFECTIVES
#460Method for identification, isolation and production of antigens to a specific pathogen
#461Method of protecting against staphylococcal infection
#462Nucleic acids encoding opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
#463Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria
#464Human tumor necrosis factor receptor TR9 antibody
#465Process for producing protein A-like protein with use of genus bacterium
#466Treatment of micro-organism infection
#467Modified SEB and prophylactics/remedies for immunopathy containing the same
#468Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use
#469Treatment of infections utilizing antibodies that bind to fibronectin binding proteins
#470Methods of producing stable B-lymphocytes
#471Production of humanized antibodies in transgenic animals
#472Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#473Methods of producing stable B-lymphocytes
#474fibrinogen binding protein gene
#475Methods and compositions for the treatment and prevention of and other bacterial infections
#476Methods and compositions for the treatment and prevention of infections
#477Cross-beta structures on microbial organisms
#478Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
#479Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#480Method of protecting against staphylococcal infection
#481Staphylococcal immunotherapeutics via donor selection and donor stimulation
#482Polypeptides and polynucleotides from coagulase-negative staphylococci
#483Method of treating staphylococcus aureus infection
#484Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#485Humanized and chimeric antibodies specific for lipoteichoic acid of GRAM positive bacteria
#486Monoclonal antibodies to the CLFA protein and method of use in treating infections
#487Method of inhibiting Candida-related infections using donor selected or donor stimulated immunoglobulin compositions
#488Use of molecules which interact with the haptoglobin receptor ligand binding
#489Collagen-binding proteins from enterococcal bacteria
#490Antimultiorganism glycoconjugate vaccine
#491Fibronectin binding protein compositions and methods of use
#492Polysaccharide vaccine for staphylococcal infections
#493antibodies
#494Treatment of micro-organism infection
#495Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
#496Antibody diversity generation
#497Method for identification, isolation and production of antigens to a specific pathogen
#498Methods and compositions for conversion of antibody activity
#499Capsular polysaccharide adhesin antigen, preparation, purification and use
#500Anti-specific antibody and nucleic acid encoding sequence thereof, and uses of the same
#501Antibody specific to , therapeutic method and detection method using same